Status:
UNKNOWN
Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Due to the emergence of an epidemic cluster in Mulhouse, a city located 100 km south of Strasbourg, Alsace was one of the first French regions to be affected by the coronavirus (SARS-CoV-2 or COVID-19...
Eligibility Criteria
Inclusion
- Adult patient (≥18 years old)
- Patient hospitalized in surgical intensive care at the New Civil Hospital between February 24 and April 15, 2020.
- Patient with a SARS-CoV-2 infection documented by RT-PCR or with lesions suggestive on chest CT.
- Patient who has given his consent for the use of his data for the purposes of this research
Exclusion
- Patient without documentation of SARS-CoV-2 infection (RT-PCR or chest scanner)
- Patient who expressed his opposition to participating in the study
- Subject under safeguard of justice
- Subject under guardianship or guardianship
Key Trial Info
Start Date :
May 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 19 2021
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04681755
Start Date
May 19 2020
End Date
May 19 2021
Last Update
December 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Strasbourg University Hospitals - Anesthesia and surgical resuscitation service
Strasbourg, France, 67091